In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research
This Special Issue published one editorial, eight articles and four reviews from approximately one hundred authors. It aimed to provide cutting-edge research on pre-clinical development and the clinical translation of radiopharmaceuticals within the molecular imaging community. The Special Issue cov...
I tiakina i:
| Hōputu: | Online |
|---|---|
| Reo: | Ingarihi |
| I whakaputaina: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Ngā marau: | |
| Urunga tuihono: | ONIX_20230623_9783036573915_26 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
| _version_ | 1869517331857670144 |
|---|---|
| collection | Directory of Open Access Books |
| description | This Special Issue published one editorial, eight articles and four reviews from approximately one hundred authors. It aimed to provide cutting-edge research on pre-clinical development and the clinical translation of radiopharmaceuticals within the molecular imaging community. The Special Issue covered radioligand development, existing radiotracer optimization, imaging agent evaluation in animal models, the clinical production of radiopharmaceuticals, and investigative research on the use of molecular imaging probes in human subjects. We appreciate all the authors’ significant contributions to this Special Issue and hope the readers will enjoy the content. |
| format | Online |
| id | doab-20.500.12854ir-100794 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1007942024-03-28T03:33:17Z In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research Yue, Xuyi nanoparticle multimodal imaging photoacoustic heterobivalent peptide Alzheimer’s disease amyloid-beta animal model astrocyte blood–brain barrier imaging metabolism microglia neuroinflammation neurotransmitter receptors positron emission tomography synaptic density vascular imaging FDG PET/CT microvasculature imaging ABC-transporter drug-induced liver injury hepatotoxicity organic anion-transporting polypeptide pharmacokinetics liver function SLC-transporter V/Q PET/CT [68Ga]Ga-MAA 68Ga-labelled carbon nanoparticles glioblastoma fluorescence guided surgery 5-ALA fluorescein NIR-AZA magnetic resonance imaging high resolution hybrid imaging psychiatric disorders extracellular vesicles (EVs) umbilical cord mesenchymal stem cell (UCMSC) diabetes I-124 positron emission tomography (PET) intravenous (I.V.) administration intra-arterial (I.A.) administration biodistribution fluorine-18 PET oxime PSMA lipophilicity radiometals copper-61 liquid targets post-processing [61Cu]Cu-DOTA-NOC [61Cu]Cu-DOTA-TOC [61Cu]Cu-DOTA-TATE FAP 99mTc-FAP inhibitor 99mTc-labeled iFAP tumor microenvironment SPECT GluN1/2B receptors NMDA [3H]ifenprodil σ1 and σ2 receptors receptor occupancy PET imaging drug development neurodegenerative diseases n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PS Biology, life sciences This Special Issue published one editorial, eight articles and four reviews from approximately one hundred authors. It aimed to provide cutting-edge research on pre-clinical development and the clinical translation of radiopharmaceuticals within the molecular imaging community. The Special Issue covered radioligand development, existing radiotracer optimization, imaging agent evaluation in animal models, the clinical production of radiopharmaceuticals, and investigative research on the use of molecular imaging probes in human subjects. We appreciate all the authors’ significant contributions to this Special Issue and hope the readers will enjoy the content. 2023-06-23T09:42:20Z 2023-06-23T09:42:20Z 2023 book ONIX_20230623_9783036573915_26 9783036573915 9783036573908 https://directory.doabooks.org/handle/20.500.12854/100794 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/7256 https://mdpi.com/books/pdfview/book/7256 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-7390-8 10.3390/books978-3-0365-7390-8 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036573915 9783036573908 220 Basel open access |
| spellingShingle | nanoparticle multimodal imaging photoacoustic heterobivalent peptide Alzheimer’s disease amyloid-beta animal model astrocyte blood–brain barrier imaging metabolism microglia neuroinflammation neurotransmitter receptors positron emission tomography synaptic density vascular imaging FDG PET/CT microvasculature imaging ABC-transporter drug-induced liver injury hepatotoxicity organic anion-transporting polypeptide pharmacokinetics liver function SLC-transporter V/Q PET/CT [68Ga]Ga-MAA 68Ga-labelled carbon nanoparticles glioblastoma fluorescence guided surgery 5-ALA fluorescein NIR-AZA magnetic resonance imaging high resolution hybrid imaging psychiatric disorders extracellular vesicles (EVs) umbilical cord mesenchymal stem cell (UCMSC) diabetes I-124 positron emission tomography (PET) intravenous (I.V.) administration intra-arterial (I.A.) administration biodistribution fluorine-18 PET oxime PSMA lipophilicity radiometals copper-61 liquid targets post-processing [61Cu]Cu-DOTA-NOC [61Cu]Cu-DOTA-TOC [61Cu]Cu-DOTA-TATE FAP 99mTc-FAP inhibitor 99mTc-labeled iFAP tumor microenvironment SPECT GluN1/2B receptors NMDA [3H]ifenprodil σ1 and σ2 receptors receptor occupancy PET imaging drug development neurodegenerative diseases n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PS Biology, life sciences In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research |
| title | In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research |
| title_full | In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research |
| title_fullStr | In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research |
| title_full_unstemmed | In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research |
| title_short | In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research |
| title_sort | in vivo nuclear molecular imaging in drug development and pharmacological research |
| topic | nanoparticle multimodal imaging photoacoustic heterobivalent peptide Alzheimer’s disease amyloid-beta animal model astrocyte blood–brain barrier imaging metabolism microglia neuroinflammation neurotransmitter receptors positron emission tomography synaptic density vascular imaging FDG PET/CT microvasculature imaging ABC-transporter drug-induced liver injury hepatotoxicity organic anion-transporting polypeptide pharmacokinetics liver function SLC-transporter V/Q PET/CT [68Ga]Ga-MAA 68Ga-labelled carbon nanoparticles glioblastoma fluorescence guided surgery 5-ALA fluorescein NIR-AZA magnetic resonance imaging high resolution hybrid imaging psychiatric disorders extracellular vesicles (EVs) umbilical cord mesenchymal stem cell (UCMSC) diabetes I-124 positron emission tomography (PET) intravenous (I.V.) administration intra-arterial (I.A.) administration biodistribution fluorine-18 PET oxime PSMA lipophilicity radiometals copper-61 liquid targets post-processing [61Cu]Cu-DOTA-NOC [61Cu]Cu-DOTA-TOC [61Cu]Cu-DOTA-TATE FAP 99mTc-FAP inhibitor 99mTc-labeled iFAP tumor microenvironment SPECT GluN1/2B receptors NMDA [3H]ifenprodil σ1 and σ2 receptors receptor occupancy PET imaging drug development neurodegenerative diseases n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PS Biology, life sciences |
| topic_facet | nanoparticle multimodal imaging photoacoustic heterobivalent peptide Alzheimer’s disease amyloid-beta animal model astrocyte blood–brain barrier imaging metabolism microglia neuroinflammation neurotransmitter receptors positron emission tomography synaptic density vascular imaging FDG PET/CT microvasculature imaging ABC-transporter drug-induced liver injury hepatotoxicity organic anion-transporting polypeptide pharmacokinetics liver function SLC-transporter V/Q PET/CT [68Ga]Ga-MAA 68Ga-labelled carbon nanoparticles glioblastoma fluorescence guided surgery 5-ALA fluorescein NIR-AZA magnetic resonance imaging high resolution hybrid imaging psychiatric disorders extracellular vesicles (EVs) umbilical cord mesenchymal stem cell (UCMSC) diabetes I-124 positron emission tomography (PET) intravenous (I.V.) administration intra-arterial (I.A.) administration biodistribution fluorine-18 PET oxime PSMA lipophilicity radiometals copper-61 liquid targets post-processing [61Cu]Cu-DOTA-NOC [61Cu]Cu-DOTA-TOC [61Cu]Cu-DOTA-TATE FAP 99mTc-FAP inhibitor 99mTc-labeled iFAP tumor microenvironment SPECT GluN1/2B receptors NMDA [3H]ifenprodil σ1 and σ2 receptors receptor occupancy PET imaging drug development neurodegenerative diseases n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PS Biology, life sciences |
| url | ONIX_20230623_9783036573915_26 |